#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4421738	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R1 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
2.	ALA4421739	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R4 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
3.	ALA4421740	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R7 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
4.	ALA4421741	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R8 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
5.	ALA4421742	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R10 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4421717	cell-based format	Patent Bioactivity Data
6.	ALA4421743	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4421717	cell-based format	Patent Bioactivity Data
7.	ALA4421744	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R38 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
8.	ALA4421745	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R44 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
9.	ALA4421746	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R3 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
10.	ALA4421747	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R5 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
11.	ALA4421748	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R9 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
12.	ALA4421749	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R13 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
13.	ALA4421750	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R16 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
14.	ALA4421751	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R39 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
15.	ALA4421752	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
16.	ALA4421753	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R41 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
17.	ALA4421754	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R42 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
18.	ALA4421755	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R43 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
19.	ALA4421756	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R45 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4421717	cell-based format	Patent Bioactivity Data
20.	ALA4421757	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R46 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4421717	cell-based format	Patent Bioactivity Data